Clinical effects of danazol on endometrial hyperplasia in menopausal and postmenopausal women
Danazol treatment of 15 menopausal and postmenopausal women with endometrial hyperplasia led to regression of hyperplastic endometrium within 2-3 months without recurrence or progression.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (4)
- W1612885883 via openalex
- W1976826900 via openalex
- W2014795587 via openalex
- W2434579782 via openalex
Cited by (12)
- Therapeutic Options for Management of Endometrial Hyperplasia: An Update 2015
- Hémorragies utérines fonctionnelles ou ménorragies idiopathiques 2008
- Effects of Hormones 2005
- Treatment of Endometrial Hyperplasia with a Danazol-Releasing Intrauterine Device: A Prospective Study 2004
- Abnormal Uterine Bleeding: Medical Treatment with Vaginal Danazol and Five-Year Follow-up 2004
- Phase II trial of danazol in advanced, recurrent, or persistent endometrial cancer: a Gynecologic Oncology Group study 2003
- Influence of vaginal danazol on uterine and brain perfusion during hormonal replacement therapy 2001
- Preventive effects of danazol on endometrial carcinogenesis in mice 2000
- Effects of Hormones 1995
- Benign Diseases of the Endometrium 1994
- Postmenopausal endometrial hyperplasia: role of danazol therapy 1994
- Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer 1993
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00